Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)

NCT01220713 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-08-27

No results posted yet for this study

Summary

The goal of this research is to serve as a demonstration project to determine the tolerability of individuals with persistent post-concussive symptoms from combat-related mild TBI (traumatic brain injury), identify dose-finding for HBO2 (Hyperbaric Oxygen) therapy, and determine the efficacy of HBO2 therapy.

Conditions

  • Mild Traumatic Brain Injury
  • Post-Concussive Syndrome

Interventions

PROCEDURE

Hyperbaric Oxygen Therapy

1.5 atm abs oxygen equivalent of 75% oxygen (balance 25% nitrogen), 40 treatments of 60 minutes each during a time period of up to ten weeks.

PROCEDURE

Hyperbaric Oxygen Therapy

2.0 atm abs oxygen equivalent of 100% oxygen (no nitrogen), 40 treatments of 60 minutes each during a time period of up to ten weeks.

PROCEDURE

Hyperbaric Oxygen Therapy

sham--air equivalent of 10.5% oxygen (balance 89.5% nitrogen), 40 treatments of 60 minutes each during a time period of up to ten weeks.

Sponsors & Collaborators

  • United States Naval Medical Center, Portsmouth

    collaborator FED
  • Hunter Holmes Mcguire Veteran Affairs Medical Center

    collaborator FED
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • David X Cifu, MD · Virginia Commonwealth University

  • Brett Hart, MD · Naval Operational Medicine Institute

  • Michelle Nichols, MSN, RN · McGuire Veterans' Affairs Medical Center

  • Justin O Alicea · Virginia Commonwealth University

  • Steven L West, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220713 on ClinicalTrials.gov